The University of Chicago Header Logo

Connection

Linda Wagner-Weiner to Child

Back to Details
This is a "connection" page, showing publications Linda Wagner-Weiner has written about Child.
Linda Wagner-Weiner
Connection Strength
0.470
Child
  1. Intravenous Immunoglobulin in Pediatric Rheumatology: When to Use It and What Is the Evidence. Pediatr Ann. 2017 Jan 01; 46(1):e19-e24.
    View in: PubMed
    Score: 0.057
  2. Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome. Pediatr Ann. 2015 Jun; 44(6):e142-7.
    View in: PubMed
    Score: 0.051
  3. Pediatric rheumatology for the adult rheumatologist. J Clin Rheumatol. 2008 Apr; 14(2):109-19.
    View in: PubMed
    Score: 0.031
  4. Evaluating Renal Disease in Pediatric-Onset Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome. Arthritis Rheumatol. 2025 May; 77(5):606-614.
    View in: PubMed
    Score: 0.025
  5. Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An ARChiVe Registry Cohort Study. Arthritis Care Res (Hoboken). 2025 Apr; 77(4):504-512.
    View in: PubMed
    Score: 0.025
  6. Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study. Ann Rheum Dis. 2024 Oct 21; 83(11):1561-1571.
    View in: PubMed
    Score: 0.024
  7. Adherence to medication by adolescents and young adults with childhood-onset systemic lupus erythematosus. Lupus. 2022 Oct; 31(12):1508-1515.
    View in: PubMed
    Score: 0.021
  8. Laboratory evaluation of children with rheumatic disease. Pediatr Ann. 2002 Jun; 31(6):362-71.
    View in: PubMed
    Score: 0.021
  9. Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2022 09; 74(9):1550-1558.
    View in: PubMed
    Score: 0.021
  10. Epstein-Barr virus burden in adolescents with systemic lupus erythematosus. Pediatr Infect Dis J. 2001 Feb; 20(2):148-53.
    View in: PubMed
    Score: 0.019
  11. Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis. J Rheumatol. 2021 07; 48(7):1073-1081.
    View in: PubMed
    Score: 0.019
  12. Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis Rheumatol. 2019 03; 71(3):451-459.
    View in: PubMed
    Score: 0.016
  13. Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis. Pediatr Rheumatol Online J. 2018 Oct 22; 16(1):65.
    View in: PubMed
    Score: 0.016
  14. Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease. Arthritis Rheumatol. 2018 09; 70(9):1508-1518.
    View in: PubMed
    Score: 0.016
  15. Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey. Pediatr Rheumatol Online J. 2017 Aug 07; 15(1):61.
    View in: PubMed
    Score: 0.015
  16. Malignancy in Pediatric-onset Systemic Lupus Erythematosus. J Rheumatol. 2017 Oct; 44(10):1484-1486.
    View in: PubMed
    Score: 0.015
  17. Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. Arthritis Rheumatol. 2016 10; 68(10):2514-26.
    View in: PubMed
    Score: 0.014
  18. A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America. Pediatr Rheumatol Online J. 2014; 12:24.
    View in: PubMed
    Score: 0.012
  19. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012 Mar; 64(3):375-83.
    View in: PubMed
    Score: 0.010
  20. Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum. 2012 Jan; 64(1):285-96.
    View in: PubMed
    Score: 0.010
  21. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus. 2010 Oct; 19(11):1315-25.
    View in: PubMed
    Score: 0.009
  22. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009 May; 60(5):1496-507.
    View in: PubMed
    Score: 0.008
  23. Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol. 2003 Feb; 30(2):394-400.
    View in: PubMed
    Score: 0.005
  24. Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis. J Rheumatol. 2000 Dec; 27(12):2938-40.
    View in: PubMed
    Score: 0.005
  25. Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis. Arthritis Rheum. 1993 Oct; 36(10):1370-4.
    View in: PubMed
    Score: 0.003
  26. Intermittent intravenous cyclophosphamide therapy for lupus nephritis. J Pediatr. 1989 Jun; 114(6):1055-60.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.